Sale!

Clopidogrel CYP2C19 Genotype Test

8,420 د.إ

-10%

The Clopidogrel CYP2C19 Genotype Test is a specialized diagnostic procedure designed to assess how an individual’s genetic makeup affects their response to clopidogrel, a medication commonly prescribed to prevent blood clots in patients with heart conditions or those who have undergone certain heart procedures. The effectiveness and metabolism of clopidogrel can vary significantly among individuals, primarily due to variations in the CYP2C19 gene. This test identifies specific genetic variants of the CYP2C19 enzyme that can influence the body’s ability to process clopidogrel, thereby helping healthcare providers to tailor treatment plans more effectively and reduce the risk of adverse drug reactions.

Performed at DNA Labs UAE, a leading facility in genetic testing, the Clopidogrel CYP2C19 Genotype Test is priced at 8420 AED. The test involves a simple and non-invasive sample collection process, after which the sample is analyzed to detect the presence of genetic variations in the CYP2C19 gene. The results of this test can significantly impact patient care, guiding clinicians in deciding whether clopidogrel is the right medication for their patient or if an alternative treatment should be considered based on the patient’s genetic profile. This personalized approach to medication management aims to improve treatment efficacy and patient safety.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

CLOPIDOGREL CYP2C19 GENOTYPE Test

Welcome to DNA Labs UAE, a leading genetic lab offering the CLOPIDOGREL CYP2C19 genotype test. This test helps determine a patient’s genetic variation in the CYP2C19 gene, which is responsible for metabolizing the drug clopidogrel.

Test Details

The CLOPIDOGREL CYP2C19 genotype test is a genetic test that identifies a patient’s genetic makeup in relation to the CYP2C19 gene. This gene is crucial in metabolizing clopidogrel, a medication used to prevent blood clots in patients with certain cardiovascular conditions like heart attacks and strokes.

Components

The test costs AED 8420.0 and requires a sample of 4 mL (2 mL minimum) of whole blood in a Lavender Top (EDTA) tube. The sample should be shipped refrigerated or frozen. Additionally, a duly filled Test Send Out Consent Form is mandatory.

Report Delivery

The sample should be sent by the 7th of the month, and the report will be delivered after 2-3 weeks.

Method

The CLOPIDOGREL CYP2C19 genotype test is conducted using the Real Time Polymerase Chain Reaction (PCR) method, specifically the Single Nucleotide Primer Extension technique.

Test Type

The test is primarily used for diagnosing heart diseases and is recommended by cardiologists.

Pre Test Information

No special preparation is required before undergoing the CLOPIDOGREL CYP2C19 genotype test.

Why is the Test Important?

The CLOPIDOGREL CYP2C19 genotype test helps identify patients who may not respond well to clopidogrel due to their genetic makeup. By determining the patient’s genetic variation in the CYP2C19 gene, healthcare professionals can create a more effective treatment plan tailored to the patient’s specific needs. This test is usually recommended before starting clopidogrel therapy to ensure the most suitable and beneficial treatment for the patient.

Test Name CLOPIDOGREL CYP2C19 GENOTYPE Test
Components
Price 8420.0 AED
Sample Condition 4 mL (2 mL min.) whole blood in 1Lavender Top (EDTA) tube. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory.
Report Delivery Sample by 7th of the month; Report after 2??3 weeks
Method Real Time Polymerase Chain Reaction (PCR),Single Nucleotide Primer Extension
Test type Heart Diseases
Doctor Cardiologist
Test Department: OS
Pre Test Information No special preparation required
Test Details

The CLOPIDOGREL CYP2C19 genotype test is a genetic test that determines the patient’s genetic variation in the CYP2C19 gene, which is responsible for metabolizing the drug clopidogrel. Clopidogrel is a medication used to prevent blood clots in patients with certain cardiovascular conditions, such as heart attacks and strokes. The test helps to identify patients who may not respond well to clopidogrel due to their genetic makeup and may require alternative treatments. This test is usually recommended before starting clopidogrel therapy to ensure the most effective treatment plan for the patient.